Phase II trial of cisplatin, tegafur plus uracil and leucovorin as neoadjuvant chemotherapy in patients with squamous cell carcinoma of the oropharynx and hypopharynx-Reference-Cited by-同舟云学术

Phase II trial of cisplatin, tegafur plus uracil and leucovorin as neoadjuvant chemotherapy in patients with squamous cell carcinoma of the oropharynx and hypopharynx

Published:2005-04 Issue:4 Volume:16 Page:447-453
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:Anti-Cancer Drugs

Author:

Wang Hung-Ming,Hsueh Chung-Tsen,Wang Cheng-Su,Chen I-How,Liao Chun-Ta,Tsai Ming-Hsui,Yeh Shih-Peng,Chang Joseph Tung-Chieh

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference31 articles.

1. Another Look at Induction Chemotherapy for Organ Preservation in Patients With Head and Neck Cancer

2. Head and Neck Cancer in 1994: a Change in the Standard of Care

3. Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III Trial

4. Phase III Trial of Initial Chemotherapy in Stage III or IV Head and Neck Cancers: a Study by the Gruppo di Studio sui Tumori della Testa e del Collo

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prophylactic Versus Reactive Megestrol Acetate Use for Critical Body Weight Loss in Patients with Pharyngeal and Laryngeal Squamous Cell Carcinoma Undergoing Concurrent Chemoradiotherapy;Nutrition and Cancer;2024-05-17

2. Current Drug Delivery Strategies for Buccal Cavity Ailments using Mouth Dissolving Wafer Technology: A Comprehensive Review on the Present State of the Art;Current Drug Delivery;2022-11-28

3. Distinct Failure Patterns in Hypopharyngeal Cancer Patients Receiving Surgery-Based Versus Radiation-Based Treatment;Annals of Surgical Oncology;2022-11-06

4. Maintenance tegafur-plus-uracil after adjuvant concurrent chemoradiotherapy may improve outcome for resected oral cavity squamous cell carcinoma with extranodal extension;Frontiers in Oncology;2022-09-28

5. Tongue conservation treatment for oral tongue squamous cell carcinoma with induction chemotherapy, surgery, and risk‐adapted adjuvant therapy: A phase II trial;Cancer Reports;2021-05-29